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potential toxicity of polystyrene 
microplastic particles
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Jinkee Hong  1 ✉
Environmental pollution arising from plastic waste is a major global concern. Plastic macroparticles, 
microparticles, and nanoparticles have the potential to affect marine ecosystems and human health. 
It is generally accepted that microplastic particles are not harmful or at best minimal to human health. 
However direct contact with microplastic particles may have possible adverse effect in cellular level. 
Primary polystyrene (PS) particles were the focus of this study, and we investigated the potential 
impacts of these microplastics on human health at the cellular level. We determined that PS particles 
were potential immune stimulants that induced cytokine and chemokine production in a size-
dependent and concentration-dependent manner.
Microplastic particles can be divided into two categories, primary and secondary. Plastic particles less than 5 mm 
in diameter are considered microplastics1. Although local and national governments in North America took 
action in 2015 to regulate the manufacture of microbeads, microplastic particles are still produced in other parts 
of the world2. Primary microplastic particles are intentionally manufactured at the microscale and are key ingre-
dients in scrubs3, handwashing soaps4, cleansers5, toothpastes6, and biomedical products7. Primary microplastic 
particles, particularly those between 1 and 5 µm in diameter, are spherical and often made of polypropylene (PP), 
polystyrene (PS), or polyethylene (PE).
Unlike primary microplastic particles, secondary microplastic particles are generated through the fragmenta-
tion of plastic litter8–10. Plastic debris is the primary source of secondary microplastic particles found in the ocean 
and soil, because the debris breaks down into mesoparticles and macroparticles. Ultraviolet (UV) radiation from 
the sun and physical forces degrade these particles into plastic microparticles and nanoparticles11,12. A recent 
study investigated the fragmentation of PS coffee cup lids, disposable plates, and PS foams irradiated with simu-
lated UV light to determine the degradation mechanism13.
Seafood is also a potential source of particulate plastic contaminants14–18. Anthropogenic debris, including 
plastic particles and fibers, was found in over 20% of individual shellfish and the gastrointestinal (GI) tracts 
of fish in a 2015 study19. The ingestion of microplastics by fish and shellfish has been demonstrated in several 
studies16,18,20.
Food, food containers, everyday products (personal care products), biomedical products, and drinking water 
are not the main sources of particulate plastic contaminants. However, they may be continuous sources of plas-
tic particles21–24. For example, one study found microplastic fragments in all types of returnable and single-use 
plastic bottles24. Other examples include facial scrubs that are commonly used for exfoliation. It is estimated 
that 1.1 million women in the UK use these scrubs every day. A typical amount for daily use is 5 mL, which 
contains between 4,594 and 94,500 microplastic particles4,5. Additionally, three out of four body exfoliants con-
tain microplastics. These primary plastic particles have the potential to pass into the sewage system4, and only 
25% of them are filtered out of water sewage treatment plants4,25. Therefore, direct contact with microplastic 
particles in everyday products is a potentially serious problem. According to one study, PS particles from labo-
ratories may be a source of primary plastic particulate contaminants26. In this study, we focused on PS nanopar-
ticles and microparticles found in the surrounding environment. Depending on their size, shape, and functional 
group chemistry, ingested microplastic particles can cause various problems. Microplastic particles cannot be 
digested, so aggregates containing biomolecules and microplastics or nanoplastics can cause gastrointestinal dys-
motility or obstruction. It is well known that size is an important cytotoxicity parameter in-vitro27,28. In a recent 
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study, 30 nm COOH-PS particles in seawater aggregated in less than 30 minutes28. The hydrodynamic diameter 
of nanoplastic particles increases with an increase in the NaCl concentration. The hydrodynamic diameter of 
PS nanoparticles (NPs) is ~100 nm when the ionic strength of NaCl is low (1–50 mM). However, PS NPs have 
been found to aggregate when the NaCl concentration is higher29. PS NPs are thus expected to aggregate readily 
in seawater. Their interactions with various impurities can harm aquatic animals and may cause side effects in 
humans. Absorbed microplastics and nanoplastics less than 1.5 µm in diameter can damage cells directly. NPs 
were recently obtained via the degradation of PS microplastics after 56 days simply by irradiating them with 
UV light, which was three times faster than degradation without UV irradiation13. These findings suggest that 
simple chemical forces can generate nanoscale particles from PS particles and lead to direct cell damage. Several 
studies have reported that microplastics <1.5 µm in diameter can penetrate tissues and result in the accumula-
tion of microplastics6,30,31. Anywhere from 1% to 4% of PS particles in the intestine are thought to migrate to the 
bloodstream. The translocation of nanoparticles is thought to be very low, and the most probable sites of accu-
mulation are Peyer’s patches in small intestine32. However, it is possible that the transfer of nanoplastics into the 
bloodstream after ingestion could lead to local inflammation or induce allergic reactions in tissues29,33–35. The 
aggregation of microplastics and nanoplastics with biomolecules and chemicals often has toxic effects. According 
to the guidelines of the World Health Organization (WHO), human exposure to styrene monomers should be 
limited to a time-weighted average (TWA) of 20 ppm (85 mg/m3) with a short-term exposure limit (STEL) of 40 
ppm (170 mg/m3)36. Chemicals used to synthesize PS particles, such as monofunctional peroxides, may also cause 
toxicity. Initiators like benzoyl peroxide and azobisisobutyronitrile are used to reduce polymerization time. Other 
chemicals used for PS synthesis include catalysts, such as zeolites and iron (III) oxides; emulsifiers; and stabilizers 
likebis(2,2,6,6-tetramethylpiperidin-4-yl) decanedioate. These chemicals are found throughout the world and are 
considered environmental contaminants. They accumulate in the food chain, predominantly in the fatty tissues of 
animals. The majority of microplastics and nanoplastics consumed by humans are found in food, food containers, 
and water18,19,31. Everyday products and contaminated soil can also be sources of primary microplastics, and their 
ingestion by humans may cause health problems4,37. The average person ingests approximately 11,000 microplas-
tic and nanoplastic particles annually by consuming seafood, such as oysters, crabs, and fish18,38. Returnable and 
single-use plastic bottles may contain as many as 15 macroparticles or nanoparticles per liter24. Microparticles 
with sizes ranging from 1 to 500 µm have been found in drinking water. Fifty percent of microplastics and nan-
oplastics are below 1.5 µm in diameter. These particles are found in fibers, fragments, and spherical foams24,39,40, 
which indicates that spherical foam microplastics and nanoplastics could be primary plastic particles. It has also 
been suggested that PS microparticles account for less than 10% of the plastic particles in untreated water and 
sediment39. Therefore, monitoring primary PS particles could reveal the origins of these pollutants.
Polystyrene is a colorless, transparent polymer composed of styrene monomers and has a specific gravity 
of 1.04–1.07 g/cm3. PS is soluble in organic solvents, such as ketones, esters, and aromatic hydrocarbons. It is 
resistant to acids, alkalis, salts, mineral oils, organic acids, and alcohols41. As a hard and solid plastic, PS is often 
used to manufacture transparent products, such as food packaging and laboratory ware. Lightweight polystyrene 
foam provides excellent thermal insulation for many applications, such as roofing, building walls, refrigerators, 
and freezers.
In this study, we focused on the potential impact of primary PS particles on human health based on the size 
and concentration of the particles rather than the effects of individual chemicals. We evaluated the potential of 
primary PS particles to cause toxicity at the cellular level. Although many organizations and research groups have 
investigated the effects of primary PS microparticles and nanoparticles on marine ecosystems42–44, it is unclear 
what effects primary PS particles have on humans. Spherical primary PS particles are used for a wide range of bio-
medical applications that directly affect humans, such as drug delivery45, imaging7,46, and labware. Exploring the 
relationship between primary PS particles and potential risks to human health is thus important for understand-
ing PS particle toxicity. In this study, we evaluated the potential of primary PS microparticles and nanoparticles 
to cause toxicity in humans based on size and concentration and investigated whether the PS particles mediated 
immune responses and allergic reactions.
Results and discussion
We hypothesized that humans couldingest PS particles from everyday products, food, biomedical products, food 
containers, and drinking water24,38. We tested six different sizes of PS particles using Human Dermal Fibroblasts 
(HDFs), Human Peripheral Blood Mononuclear Cells (PBMCs), and the Human Mast Cell line (HMC-1)to 
determine their cytotoxic potential (Fig. 1).
Characterization of PS particles. Scanning electron microscope (SEM) images were used to exam-
inethe morphologies of individual platinum-coated PS particles (Fig. 2A–F) in aggregates. The smaller par-
ticles were more likely to aggregate due to Van der Waals interactions with Na+or Ca2+ in the buffer. The 
zeta potential of 460 nm PS particles was −2.2 ± 0.1 mV (Fig. 2G–F), while the zeta potentials of the other 
PS particles were closer to zero. The formation of PS nanoparticle aggregates could be explained by the 
Derjaguin-Landau-Verwey-Overbeek (DLVO) theory. According to the DLVO theory, small particles carry less 
charge than large particles at pH 7. The electrical double layer (EDL) repulsion forces between small particles at 
a given ionic strength are thus smaller47. PS particles with small negative charges tended to move closer to one 
another as the ionic strength of NaCl increased to 137 mM in PBS buffer. In addition, all of the PS particles were 
uniform in size (Fig. 2D–F).
Cytotoxicity tests. We investigated the responses of human-derived HDFs, HMC-1 cells, PBMCs, and other cells 
to the PS particles. HDFs are the predominant cells in stromal tissue, which plays an important role in wound 
healing process and also provides a protective barrier to prevent the absorption of PS particles. Human mast cells 
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Figure 1. Illustration of the PS particle intake pathways of three cell lines. Human intake of PS particles from 
personal care products can occur via absorption through theskin. Intake can also occur through the ingestion 
of PS particles infood, food containers, drinking water, or biomedical products. We evaluated the potential of 
primary PS microparticles and nanoparticles tocause toxicity in humans based on the size and concentration of 
the particles in human cells.
Figure 2. SEM images and zeta potentials of PS particles. (A) 460 nm PS nanoparticles. (B) 1 µm PS particles. 
(C) 3 µm PS particles. (D) 10 µm PS particles. (E) 40 µm PS particles. (F) 100 µm PS particles (scale bar = 
200 nm, 1 µm, 2 µm, 10 µm, and 20 µm). (G) Zeta potentials of the PS particles.
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were selected for this study, because they exhibited many of the key characteristics of tissue mast cells. These 
included the expression of histamine, tryptase, and heparin, which could indicate a close relationship between 
PS microparticles, the human immune system, and hypersensitivity48. The behavior of isolated PBMCs, such as 
the expression of cytokines, could provide unique information about the human immune response to PS parti-
cles in the body. The cells were completely coated with PS particles (1 mg/mL) during treatment. A lack of HDFs 
toxicity might indicate that primary PS particles are less damaging to organs and skin. None of the PS particles 
caused significant cytotoxicity in the HDF cells or the PBMCs (Fig. 3) at concentrations up to 500 µg/mL. We also 
included a PS concentration above 500 µg/mL in the experimental design. The viability of HDF cells treated with 
3 µm PS particles at a concentration of 1,000 µg/mL was reduced by 40% (**p < 0.001), while the viability of the 
PBMCs did not decrease. Cell viability profiles against PBMCs are shown in Fig. 3G–I. It could be concluded that 
PS particles are not cytotoxic to HDFs and PBMCs in usual condition but might cause damage to skin in extreme 
high concentration condition.
The intake of PS particles through food, daily products, and biomedical products was estimated. According 
to the Sigma datasheet, the average weight of a 3 µm PS particle was 1.5 × 10−8 mg. Based on reported data, we 
calculated amaximum intake of 11,000 plastic particles per person annually through food. Humans can poten-
tially consume up to 325 plastic particles per liter of drinking water. Based on the recommendation to drink two 
liters of water per day, a person may consume up to 237,250 plastic particles per year. A maximum annual intake 
of 248,250 plastic particles including plastic particles from drinking water could thus be expected18,39,49–51, which 
could be converted to 4 µg/year assuming a PS particle size of 3 µm. We calculated the annual intake of PS par-
ticles assuming that the specific gravities, sizes, and shapes of the plastic particles varied. The maximum annual 
consumption per person can exceed 133 mg/year if the plastic particles are larger than 100 µm in diameter (More 
than plastic particles in size 100 µm represents a volumetric increase of 333 compared to 3 µm particles wherea-
specific gravity is 1.04–1.07 g/cm3). The maximum intake of PS particles from personal care or biomedical prod-
ucts based on a 5 mL volume of product ranged from 4,594 to 94,500 particles per day4,52,53. Based on this range, 
we estimated that up to 35 × 106 primary plastic particles were being used annually. Assuming a particle size of 
<3 µm or >100 µm, this was equivalent to a primary plastic particle intake of 0.5–18,860 mg per person through 
scrubbing alone. We thus increased the estimated amount of total human exposure to primary plastic particles to 
0 to19,000 mg y−1L−1. It has been reported that less than 10% of plastic waste is comprised of PS particles39. We 
Figure 3. Cytotoxicity of PS particles. (A) 460 nm PS nanoparticles on HDFs. (B) 1 µm PS particles on HDFs. 
(C) 3 µm PS particles on HDFs. (D) 10 µm PS particles on HDFs. (E) 40 µm PS particles on HDFs. (F) 100 µm 
PS particles on HDFs. (G) 460 nm PS nanoparticles on PBMCs. (H) 3 µm PS particles on PBMCs. (I) 10 µm PS 
particles on PBMCs.
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calculated an average individual PS particle intake of 0–19 mg y−1 L−1, or 0–19 µg/mL, with particles ranging in 
size from nanometers to micrometers. We assumed the PS particles were applied over a given area at the maxi-
mum concentration for a specific time to monitor the biological response.
confocal imaging. The mechanism of cellular uptake depends on the size and surface charge of the particles. 
Uptake of particles smaller than 700 nm occurs via receptor-mediated endocytosis54, whereas larger particles are 
taken up via phagocytosis55. NH2-terminated polystyrene nanospheres have been reported to be highly toxic to 
RAW 264.7 macrophages, epithelial cells, and human microvascular endothelial hepatoma cells56. This was attrib-
uted to the deposition of particles in the cytosol, which caused an increase in mitochondrial Ca2+ uptake and cell 
death. Negatively charged polymeric nanoparticles less than 500 nm in diameter tended to accumulate efficiently 
in mice tumors57. Based on these results, 460 nm PS-FITC particles were chosen for our study. PS microparti-
cles could be transformed into nanoparticles13, so we thought the results of these studies would be helpful for 
understanding the toxicity of PS particles. We also tested to determine whether 460 nm PS particles induced a 
different biological response. The 460 nm FITC-labeled PS nanoparticles allowed us to determine the location of 
particles within the cells after endocytosis (Fig. 4). The PS-FITC particles were mainly located in the cytoplasm 
of phagocytic cells, such as neutrophils and macrophages, whereas phagocytosis by lymphocyte-like cells was not 
indicated (Fig. 4A) in the Z-section images57. Similar to our observation in the PBMCs, the PS-FITC particles 
in HDF cells were mostly located in the cytoplasm, which indicated successful intake of the particles (Fig. 4B).
Hemolysis test. An in-vivo hemolysis assay was performed to evaluate the compatibility of PS particles 
with blood, which would enable us to identify severe acute toxic reactions in the RBCs58. Hemoglobin is an 
iron-containing oxygen-tranport metalloprotein, which has a significant role in the transport of oxygen from 
lungs to cells and tissues59. Good correlations between in-vitro hemolysis assays and in-vivo toxicity have been 
demonstrated in several studies60,61. The results of these studies suggest that polymers are generally harmful to 
cells, although the magnitude of toxicity depends on the concentration, exposure time, and cationic nature of 
the polymers. Microplasticparticles less than 5 µm in diameter exerted hemolytic effects on RBCs owing to their 
surface charges and aggregation in highly saline buffer (*p < 0.03, Fig. 5A–C). Aggregates of plastic particles and 
biomolecules release chemicals that also have cytotoxic effects62–65. We investigated RBC hemolysis after direct 
contact with PS particles in different concentrations and sizes. PS particles more than 10 µm in diameter cannot 
penetrate blood vessels. However, the observed hemolytic effects indicated that direct contact resulted in cyto-
toxicity. PS particlesless than 5 µm in diameter had a hemolytic effect of approximately 4% relative to the control. 
This implied that the smaller particles had a stronger tendency to aggregate due to size and high concentration 
had effect on RBC hemolysis. The induction of hemolysis depended only on size, not concentration. PS particles 
smaller than the RBCs, which had an average diameter of 6–8 µm, were more cytotoxic at each concentration due 
Figure 4. Confocal images of PS particles in cells. (A) Fluorescent images of 460 nm PS-FITC nanoparticles 
in PBMCs after DAPI staining (scale bar = 10 µm). Right: Z-section images. (B) Fluorescent images of 460 nm 
PS-FITC nanoparticles taken up by HDFs collected after DAPI staining (scale bar = 50 µm). Right: Z-section 
images.
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to their large surface areas. In contrast, large PS particles did not have any hemolytic effect on RBCs (Fig. 5D–F). 
Although the hemolysis index shown in this study was not evident66, hemolysis was related with particle size in 
negative correlation. Thus, the hemolytic adverse effect in vivo of nanoparticles should be further investigated, 
especially for the small nanoparticles.
Cytokine profiles. The risks of microplastic ingestion in animal tests depend on the degree of exposure and the 
size of the affected area16. Translocation, redistribution, and retention are major concerns67,68. As with pollen 
and dust, direct contact with plastic particles may induce primary body defense mechanisms for ejection, such 
as tearing, sputum production, sneezing, and coughing69. Microparticles in the small intestine resulting from 
absorption through the skin and by cells were transferred to other bodily tissues via blood vessels in animal 
tests, wherecell-mediated defense mechanisms occurred67. In such cases, plastic microparticles can be detected 
in the lumen of blood and lymph vessels within minutes70,71. Absorption of smaller plastic nanoparticles and 
microparticles in the digestive tract proceeds via pinocytosis and vesicular phagocytosis by phagocytes72–74. These 
processes depend on particle size. The findings of several studies suggest that plastic microspheres 50–100 nm in 
diameter are more readily absorbed through Peyer’s patches and villi in the gut than particles with larger diame-
ters of 300–3,000 nm75, and that surface charge and hydrophilicity increase the uptake affinity76–78.
In this study, we evaluated the cytokine release profiles of immune cells to determine whether inflammation 
could be triggered by treatment with PS particles. We also investigated whether cytokine release occurred in 
a size- or concentration-dependent manner. Interleukin 2 (IL-2) is one of the most common cytokines, and it 
is involved in the control of cell tolerance and immunity. IL-2 is a T-cell growth factor (TCGF) that has been 
detected insupernatants obtained from mitogen-stimulated peripheral blood lymphocytes. IL-2 is produced 
predominantly by activated CD 4+ an CD 8+T lymphocytes79. TNF-α serves as an immune mediator for cell 
adhesion, migration, angiogenesis, and apoptosis. TNF-α is a pro-inflammatory cytokine produced by bone 
marrow-derived cells, such as primarily by macrophages and also by broad types of cells (lymphocytes, mast 
cells, endothelial cells and so on), after stimulation with various agents80. The upregulation of these cytokines is a 
potential indicator of an immune response and inflammation. IL-6 acts as both a pro-inflammatory cytokine and 
an anti-inflammatory myokine. IL-6 is produced in response to infections and tissue injuries, and it contributes 
to the host defense by stimulating the acute-phase response81. IL-10 is an anti-inflammatory cytokine that inhibits 
the activity of Th1 cells, NK cells, and macrophages during infection82.
The ELISA results (Fig. 6A–C) showed an increase in the secretion of TNF-α by treatment with PS particles 
less than 1 µm in diameter at a concentration of 500 µg/mL (*P < 0.03) and a significant change in the secretion 
of IL-6 by treatment with PS particles less than 10 µm in diameter at a concentration of 500 µg/mL (*P < 0.04, 
Fig. 6D–F). However, IL-2 secretion by treated cells and the control samples did not differ (Fig. 6G-I). This indi-
cates that high concentration of small PS particles could trigger inflammation via innate immune system rather 
than via adaptive immune system. Along with confocal imaging result (Fig. 4A), we suggest that the immune 
cells are able to phagocytose PS particles and may have recognized them as pathogens. These results are consist-
ent with previous studies which showed that PS particles less than 3 µm in diameter accelerate phagocytosis by 
Figure 5. Hemolysis of RBCs after contact with PS particles. (A) 460 nm PS nanoparticles. (B) 1 µm PS 
particles. (C) 3 µm PS particles. (D) 10 µm PS particles. (E) 40 µm PS particles. (F) 100 µm PS particles. 5% tx-
100 served as the positive control. Cntl indicates no treatment. Absorbance was measured at 540 nm.
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increasing the production of cytokines, including IL-1 and IL-6. These cytokines are secreted by macrophages, 
which are related to innate immunity and inflammation83,84. IL-10 suppresses or regulates the inflammatory 
response of antigen presenting cells (APCs), such as dendritic cells and macrophages, and limits the adaptive 
Figure 6. Cytokine profiles of TNF alpha, IL-2, IL-6, IL-10, and histamine. TNF-α secretion induced by PS 
particles of various sizes at concentrations of (A) 500 µg/mL, (B) 100 µg/mL, and (C) 10 µg/mL. IL-2 secretion 
induced by PS particles of various sizes at concentrations of (D) 500 µg/mL, (E) 100 µg/mL, and (F) 10 µg/mL. 
IL-6 secretion induced by PS particles of various sizes at concentrations of (G) 500 µg/mL, (H) 100 µg/mL, and 
(I) 10 µg/mL. IL-10 secretion induced by PS particles of various sizes at concentrations of (J) 500 µg/mL, (K) 
100 µg/mL, and (L) 10 µg/mL. (M) Histamine profiles after treatment with 500 µg/mL PS particles of different 
sizes. Cntl: no treatment. LPS: 2.5 µg/mL.
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response of CD4 + T cells. No increase in IL-10 secretion was observed under any of the experimental conditions 
(Fig. 6J–L). This indicated that the early stage of inflammation was triggered by the phagocytosis of PS particles 
by macrophage-like cells, and that the PS particles would not down-regulate the immune response. Although the 
effects of PS particles at lower concentrations and those of larger PS particles during the early stage of inflamma-
tion were less obvious, PS particles thus had the potential to cause toxicity by triggering inflammation in a size- 
and concentration-dependent manner.
Histamine profiles. The histamine assay was performed using PS particles with different sizes at a high con-
centration of 500 µg/mL, which induced IL-6 secretion (Fig. 6M). Unlike the results of a previous study on PP 
particles49, PS particles with different sizes did not generate differences in histamine release relative to the control. 
MHC-1 mast cells have a key function at the interface between innate and adaptive immunity, and they are pri-
mary effectors of immediate hypersensitivity. Mast cell-derived TNF-α has been reported to have a particularly 
important role in allergic inflammation. The secretion of IL-2 was not affected by treatment with PS particles 
in our study. However, this may indicate that PS particles cause acute inflammation without the involvement of 
histamines, and that they are more likely to activate innate immunity than adaptive immunity.
We conducted tests with HDFs and PBMCs to determine whether primary PS particles could cause inflam-
mation and cytotoxic effects in humans without histamine mediation. PS particles with diameters of 0.46, 1, 3, 
10, 40, and 100 µm and similar zeta potentials (1 ± 2 mV) were used for this experiment. The cytotoxicity results 
indicated that PS particles concentrations at <500 µg/mL did not reduce the viability of HDF cells and PBMCs. 
However, a high concentration (1,000 µg/mL) caused cytotoxicity in up to 50% of the HDF cells. PS particle size 
and surface charge were important factors in cytotoxicity. According to a recent study, NH2-labeled polystyrene 
nanoparticles were highly toxic to RAW 264.7 macrophages. Similar to our observations, the PS nanoparticles 
accumulated in the cytoplasm and induced calcium uptake in the mitochondria, which resulted in cell death56. 
Human macrophages could selectively phagocytose PS nanoparticles, particularly COOH-terminated PS parti-
cles. The THP-1 human monocytic cell line was more likely to endocytose the NH2-terminated PS nanoparticles. 
Another study showed that PS particles of various sizes accumulated in the livers, gills, and intestines of zebrafish 
and caused inflammation85.
conclusions
Although the migration of styrene monomers in foods and food contact materials (FCMs)86 is a concern, polysty-
rene products are useful for food packaging87,88 and are thought to be harmless. We confirmed that PS particles 
were not toxic to human cells at an experimental dosage of approximately 500 µg/mL. PS particles with diame-
ters of 10–100 µm were not significantly cytotoxic. However, smaller PS particles with diameters of 460 nm and 
1 µm affected RBCs. The small PS particles had larger surface areas than the larger PS particles. The adhesion 
of small PS particles to RBCs was enhanced by weak interactive forces, such as van der Waals forces, which led 
to hemolysis64. Most of the PS particles were located in the cytoplasm of HDF cells and PBMCs 24 hours after 
uptake. PS-FITC particles were observed in phagocytic PBMCs, such as neutrophils and macrophages, but not 
in lymphocytes. IL-2 secretion did not increase after treatment with PS particles under any of the experimen-
tal conditions. Therefore, PS particles seems not induce adaptive immunity secretion of TNF alpha increased 
after treatment with a high concentration of small PS particles, and IL-6 secretion increased after treatment with 
PS particles less than 3 µm in diameter at a concentration of 500 µg/mL. IL-6 is one of the main indicators of 
early-stage inflammation, so the intake of small PS particles may induce local inflammation in tissues and organs. 
We also measured IL-10 and histamine secreted by HMC-1 cells after treatment with ahigh concentration of PS 
particles. The PS particles did not cause an increase in histamine secretion. Thus, they were not likely to induce 
an allergic reaction orhistamine-mediated inflammation. The uptake of PS particles occurredmainly through 
end ocytosis and phagocytosis by phagocytic cells. This induced the release of pro-inflammatory cytokines that 
caused local inflammation rather than direct cytotoxicity. Smaller PS particles were generally not toxic to diverse 
human cells. However, direct contact with RBCs might cause hemolysis, and PS particles inhigher concentrations 
induced early-stage inflammation. The effects of secondary PS plastic particles and PS particles with different 
shapes should be studied in the future. To avoid the adverse effect of high concentration of PS nanoparticles, PS 
particles collected directly from the ocean and soil should also be monitored.
Methods
The experimental protocol was reviewed and approved by the Institutional Animal Care and Use Committee at 
Chung-Ang University.
Materials. All experiments were repeated at least three times with three samples each. Polystyrene particles 
labeled with fluorescein isothiocyanate (PS-FITC) with diameters of 460 nm were typically used as a label for 
detection, 1 µm, and 3 µm were purchased from SigmaAldrich (USA). PS particles with diameters of 10 µm, 
40 µm, and 100 µm were purchased from Cospheric (USA). The PS particles were suspended in either PBS or 
cell culture medium prior to the experiment. Drabkin’s reagent, lipopolysaccharide (LPS), Triton X-100 (tx-
100), and CCK-8 (Cell counting kits-8) cell counting kits were purchased from SigmaAldrich (USA). A human 
mast cell line1 (HMC-1) suspension was purchased from Merck Millipore (USA), and human dermal fibroblasts 
(HDFs) were obtained from Sigma (USA). Peripheral blood mononuclear cells (PBMCs) were purchased from 
CTL (USA). Due to human specimen control regulations, defibrinated sheep’s blood (Kisan Bio, Korea) was used 
instead. Human IL-2, IL-6, IL-10, and TNF-alpha (TNF-α) enzyme-linked immunosorbent assay (ELISA) kits 
were purchased from BioLegend (USA). Phosphate-buffered saline (PBS), Dulbecco’s phosphate-buffered saline 
(DPBS) without Ca2+ and Mg2+, and Roswell Park Memorial Institute (RPMI) 1640 medium containing 10% fetal 
bovine serum (FBS) were obtained from Gibco (Waltham, MA, USA).
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Characterization of PS particles. PS particles were dispersed in PBS (pH 7.4), and their surface charges 
were determined via zeta potential analysis using a Zetasizer (Malvern Instruments, UK). SEM images of 
platinum-coated samples were captured using a field-emission scanning electron microscope (FE-SEM) pur-
chased from Carl Zeiss (Oberkochen, Germany).
Cytotoxicity tests. Direct contact with PS particles has the potential to damage to skin. Human dermal fibro-
blasts (HDFs, Amsbio, USA) are the most ubiquitous cells in complex organisms. They are the predominant 
cells in stromal tissue, which plays an important role in the repair and healing of damaged organs by providing 
a protective barrier against PS particle absorption89. We used commercially available PBMC immune cellsto test 
the immunological response. The PBMCs were thawed, cultured for 16 h prior to use, and plated at 1 × 105 
cells per well in a 96-well plate. PS particles were added to the wells to final concentrations of 0, 1, 10, 100, 500, 
and 1,000 µg/mL. Cntl denoted no treatment, and tx-100 was added to the wells to serve as a positive control 
(n = 4). The PBMCs were cultured for four days in RPMI 1640, and HDFs were cultured in low-glucoseDulbecco’s 
Modified Eaglemedium (DMEM) with 10% fetal bovine serum. The cultures were prepared with 1% penicillin 
and streptomycin and incubated under 5% CO2 at 37 °C. Based on the hypothesis that people could be exposed to 
more than 20 mg of particles per year, we included high PS concentrations in the experimental design to observe 
how the particles affected cells. HDFs were seeded at a concentration of 5 × 104 cells per well in a 96-well plate 
and treated with PS particles at different concentrations. Briefly, 10 µL of the CCK-8 reagent was added to the 
wells following addition of the PS particles. Absorbance was measured at 450 nm and compared to absorbance by 
the negative (N, no treatment) and positive (P) controls in 5% Triton X-100.
Confocal imaging. Prior to confocal imaging, the cells were fixed with 4% paraformaldehyde (PFA) for 
1 h. They were then permeabilized with 1% Triton X-100 for 30 minutes, washed, and stained with 3 nM 
4′,6-diamidino-2-phenylindole (DAPI) solution to make the nuclei distinguishable. Confocal images were 
obtained using a LSM 710 laser scanning microscope (Carl Zeiss, Oberkochen, Germany).
Hemolysis tests. In-vivo hemolysis tests were performed to identify severe acute toxic responses in RBCs induced 
by the PS particles. For this experiment, we assumed direct contact between the PS particles and the RBCs. We 
used sheep RBCs for the study, because their structures and functions were similar to those of human RBCs. 
Sheep’s blood (20 mL) was mixed with 20 mL PBS, then centrifuged at 500 g for 30 minutes. All of the supernatant 
was removed via aspiration. The purified RBCs were mixed with PBS in a 1:2 (v/v) ratio, and 1 mL aliquots of the 
RBC mixture were treated with PS particles in final concentrations of 0, 1, 10, 100, 500, and 1,000 µg/mL. The 
mixtures were agitated on a rotary mixer for 12 h. After the reaction, the supernatants were collected and mixed 
with Drabkin’s reagent in a 1:1 (v/v) ratio. The mixtures were held at room temperature for 20 minutes, and the 
degree of hemolysis was analyzed by measuring UV absorbance at 540 nm.
Cytokine profiling. We focused on the induction of pro-inflammatory cytokine expression in HMC-1 and 
PBMC samples prepared in 200 µL aliquots of the culture medium. The supernatants were collected four hours 
after treating the cells with PS particles. Interleukin 6 (IL-6) secretion in the early stages of PS treatment could 
indicate a relationship between IL-6 and the inflammatory response. HMC-1 cells were cultured to 80% conflu-
ency in T-25 flasks. PS particles with sizes ranging from 460 nm to 100 µm were added, and the ELISA assay was 
performed to evaluate total histamine expression. The PBMCs provided unique information about the expression 
of constituent cytokines that could indicate an immune response against PS particles in vivo. The PBMCs were 
thawed and cultured for 16 h prior to the experiment. We then plated 5 × 105 cells per well in a 24-well plate, and 
PS particles were added to final concentrations of 0, 10, 100, and 500 µg/mL. The plate was incubated for four 
days, and 2.5 µg/mL LPS was used as the positive control. The ELISA assay was performed according to manu-
facturer’s protocol.
Histamine profiling. Histamines, including the catecholamines dopamine and epinephrine and spermine, a 
polyamine, are produced as part of the local immune response underlying histamine-mediated inflammation. 
Histidine is converted to histamine by histidine decarboxylase, which is stored in granules in mast cells and 
basophils90,91. Histamine is released from the granules and is known to contribute to allergic reactions, asthma, 
eczema, and coughing. It plays an important role as a chemical mediator to accelerate mucus production in 
glands, bronchial smooth muscle contraction, hypertrophy, and the enlargement of peripheral blood vessels92,93, 
histamine release is induced by reactions between the antibodies on mast cells and antigens. Histamine alsohas 
a critical role in the Ig E-mediated allergic response. Therefore, histamine secretion in vitro was evaluated to 
determine whether or not the PS particles were allergens93. The HMC-1 cells were thawed, seeded at 5 × 105 cells/
mL in a 96-well plate, and incubated for 24 h. They were then treated with PS particles with different sizes and 
concentrations for 48 h. After treatment, 200 µL of each supernatant was collected and analyzed using a histamine 
ELISA kit according to the manufacturer’s protocol.
Statistical analysis. GraphPad Prism software94 was used for statistical analysis and graphical representa-
tion of the data. ImageJ95 was used to determine the particle count from optical microscope images and to esti-
mate the fluorescence intensity in the experiments. Student’s t-tests and ANOVA were performed to analyze the 
data. Non-significant values are indicated by NS in the results section. P-values of less than 0.05 and 0.001 are 
indicated by * and **, respectively.
Ethics Approval and Consent To Participate. No tests, measurements, or experiments were performed 
on humans in this work.
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 71. Von Moos, N., Burkhardt-Holm, P. & Köhler, A. Uptake and effects of microplastics on cells and tissue of the blue mussel Mytilus 
edulis L. after an experimental exposure. Environ. Sci. Technol. 46, 11327–11335 (2012).
 72. Prietl, B. et al. Nano-sized and micro-sized polystyrene particles affect phagocyte function. Cell biology and toxicology 30, 1–16 
(2014).
 73. Nicolete, R., dos Santos, D. F. & Faccioli, L. H. The uptake of PLGA micro or nanoparticles by macrophages provokes distinct in vitro 
inflammatory response. International immunopharmacology 11, 1557–1563 (2011).
 74. Delie, F. Evaluation of nano-and microparticle uptake by the gastrointestinal tract. Advanced drug delivery reviews 34, 221–233 
(1998).
 75. Florence, A., Sakthivel, T. & Toth, I. Oral uptake and translocation of a polylysine dendrimer with a lipid surface. Journal of 
Controlled Release 65, 253–259 (2000).
 76. McClean, S. et al. Binding and uptake of biodegradable poly-DL-lactide micro-and nanoparticles in intestinal epithelia. Eur. J. 
Pharm. Sci. 6, 153–163 (1998).
 77. Win, K. Y. & Feng, S.-S. Effects of particle size and surface coating on cellular uptake of polymeric nanoparticles for oral delivery of 
anticancer drugs. Biomaterials 26, 2713–2722 (2005).
 78. Awaad, A., Nakamura, M. & Ishimura, K. Imaging of size-dependent uptake and identification of novel pathways in mouse Peyer’s 
patches using fluorescent organosilica particles. Nanomed. Nanotechnol. Biol. Med. 8, 627–636 (2012).
 79. Bornstein, S., Rutkowski, H. & Vrezas, I. Cytokines and steroidogenesis. Mol. Cell. Endocrinol. 215, 135–141 (2004).
 80. Feuerstein, G., Liu, T. & Barone, F. Cytokines, inflammation, and brain injury: role of tumor necrosis factor-alpha. Cerebrovasc. 
Brain Metab. Rev. 6, 341–360 (1994).
 81. Nemeth, E. et al. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. 
The Journal of clinical investigation 113, 1271–1276 (2004).
 82. de Waal Malefyt, R., Abrams, J., Bennett, B., Figdor, C. G. & De Vries, J. E. Interleukin 10 (IL-10) inhibits cytokine synthesis by 
human monocytes: an autoregulatory role of IL-10 produced by monocytes. J. Exp. Med. 174, 1209–1220 (1991).
 83. Green, T., Fisher, J., Stone, M., Wroblewski, B. & Ingham, E. Polyethylene particles of a ‘critical size’are necessary for the induction 
of cytokines by macrophages in vitro. Biomaterials 19, 2297–2302 (1998).
 84. Shanbhag, A. S., Jacobs, J. J., Black, J., Galante, J. O. & Glant, T. T. Macrophage/particle interactions: effect of size, composition and 
surface area. J. Biomed. Mater. Res. 28, 81–90 (1994).
1 2Scientific RepoRtS |         (2020) 10:7391  | https://doi.org/10.1038/s41598-020-64464-9
www.nature.com/scientificreportswww.nature.com/scientificreports/
 85. Lu, Y. et al. Uptake and accumulation of polystyrene microplastics in zebrafish (Danio rerio) and toxic effects in liver. Environ. Sci. 
Technol. 50, 4054–4060 (2016).
 86. Tawfik, M. S. & BaAbdullah, H. Migration levels of monostyrene in most vulnerable foods handled and stored in polystyrene 
containers and their impact on the daily intake. Pakistan Journal of Food Sciences 24, 57–63 (2014).
 87. Appendini, P. & Hotchkiss, J. H. Review of antimicrobial food packaging. Innovative Food Science & Emerging Technologies 3, 
113–126 (2002).
 88. Cassidy, K. & Elyashiv-Barad, S. US FDA’s revised consumption factor for polystyrene used in food-contact applications. Food 
additives and contaminants 24, 1026–1031 (2007).
 89. Froget, S. et al. Wound healing mediator production by human dermal fibroblasts grown within a collagen-GAG matrix for skin 
repair in humans. Eur. Cytokine Netw. 14, 60–64 (2003).
 90. Schayer, R. W. The metabolism of histamine in various species. Br. J. Pharmacol. Chemother. 11, 472–473 (1956).
 91. Steinhoff, M., Steinhoff, A., Homey, B., Luger, T. A. & Schneider, S. W. Role of vasculature in atopic dermatitis. J. Allergy Clin. 
Immunol. 118, 190–197 (2006).
 92. Mekori, Y. A. & Metcalfe, D. D. Mast cells in innate immunity. Immunol. Rev. 173, 131–140 (2000).
 93. Galli, S. J. et al. Mast cells as “tunable” effector and immunoregulatory cells: recent advances. Annu. Rev. Immunol. 23, 749–786 
(2005).
 94. Prism, G. Graphpad software. San Diego, CA, USA (1994).
 95. Schneider, C. A., Rasband, W. S. & Eliceiri, K. W. NIH Image to ImageJ: 25 years of image analysis. Nature methods 9, 671 (2012).
Acknowledgements
This work was supported by the Basic Science Research Program through the National Research Foundation 
of Korea (NRF) funded by the Ministry of Science and ICT (NRF-2017R1E1A1A01074343) and Basic Science 
Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of 
Education (NRF-2019R1A6A3A03034115). We also received funding from the Bio and Medical Technology 
Development Program of the National Research Foundation (NRF) funded by the Ministry of Science & ICT 
(NRF-2016M3A9C6917405).
Author contributions
J.S.H., D.H.C. and S.R.H. performed the experiments and analyzed the data. J.S.H., J.H.C. and J.K.H. designed the 
experiments. J.S.H., S.Y.J. and J.K.H. wrote the manuscript. All authors reviewed the manuscript.
competing interests
The authors declare no competing interests.
Additional information
Correspondence and requests for materials should be addressed to S.Y.J., J.C. or J.H.
Reprints and permissions information is available at www.nature.com/reprints.
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and 
institutional affiliations.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International 
License, which permits use, sharing, adaptation, distribution and reproduction in any medium or 
format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Cre-
ative Commons license, and indicate if changes were made. The images or other third party material in this 
article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the 
material. If material is not included in the article’s Creative Commons license and your intended use is not per-
mitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the 
copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
 
© The Author(s) 2020
